SCHEMBL3101033

SCHEMBL3101033

CCCCN(c1c(OC)nn2c(-c3c(OC)cc(COCC)cc3OC)csc12)C1CCOCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL4279662 0.99 CRHR1 (0.98) CRHR1
Phosphoric Acid SCHEMBL3103060 0.96 CRHR1 (0.93) CRHR1
SCHEMBL1613462 0.94 CRHR1 (1.00) CRHR1
SCHEMBL3101044 0.94 CRHR1 (1.00) CRHR1
SCHEMBL1614582 0.93 CRHR1 (0.95) CRHR1
Bromide SCHEMBL3238098 0.93 CRHR1 (0.98) CRHR1
SCHEMBL3107664 0.91 CRHR1 (0.87) CRHR1
SCHEMBL3104922 0.91 CRHR1 (0.95) CRHR1
SCHEMBL1615225 0.91 CRHR1 (1.00) CRHR1
SCHEMBL1614189 0.91 CRHR1 (1.00) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431603-B2 3-phenylpyrazolo[5,1-b]thiazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-04-30 US claimed
EP-2266990-B1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUND EISAI R&D MAN CO LTD (JP) 2012-09-26 EP claimed
US-8431603-B2 3-phenylpyrazolo[5,1-b]thiazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-04-30 US disclosed
US-8431603-B2 3-phenylpyrazolo[5,1-b]thiazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-04-30 US disclosed
US-8431603-B2 3-phenylpyrazolo[5,1-b]thiazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-04-30 US disclosed
EP-2266990-B1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUND EISAI R&D MAN CO LTD (JP) 2012-09-26 EP disclosed
EP-2266990-B1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUND EISAI R&D MAN CO LTD (JP) 2012-09-26 EP disclosed
EP-2266990-A1 3-PHENYLPYRAZOLOÝ5,1-b¨THIAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2010-12-29 EP disclosed
WO-2009128383-A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUND エーザイ・アール・アンド・ディー・マネジメント株式会社 (JP) 2009-10-22 WO disclosed
US-20090259049-A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUNDS EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-10-15 US disclosed
US-20090259049-A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUNDS EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-10-15 US disclosed
US-20090259049-A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUNDS EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259049-A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUNDS CRHR1, AGTR1, CRHR2 CRHR1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.